LTP Special Column

Categories
LTP Special Column (237) Fintech (23) Blockchain / Digital Asset (5) ESG (24) Mergers & Acquisitions / Cross-border Investment (11) Capital Market / Securities (249) General Corporate Affairs (154) Infrastructure Projects / Construction Laws (106) Trade Secret (18) Trademark (45) Patent (31) Copyright (78) Competition Law (80) Biotech (32) Energy (13) Media / Entertainment (55) Employment Law (118) Personal Data Protection (38) Arbitration / Litigation (329) Tax (56) Environmental Protection Law (8) PRC Investment and Legal Compliance (34) Other Areas (231)

August 2022

Post-Epidemic Era – Bottlenecks and Reflections on Taiwan's E-chop System

August 2022

Feature Articles on the Act for the Development of Biotech and Pharmaceutical Industry of Taiwan (VI) –The MOEA of Taiwan Pre-announced Draft Sub-law: Regulations Governing Management of Research Personnel’s Concurrent Holding of Jobs and Investments by Contribution of Technology to Start-up Biotech and Pharmaceutical Company

August 2022

Feature Articles on the Act for the Development of Biotech and Pharmaceutical Industry of Taiwan (V) –The Draft Regulations Announced by the MOEA and MOF of Taiwan: Regulations Governing the Tax Deferral for a Top Executive or Technology Investor in Biotech and Pharmaceutical Companies, Regulations Governing Biotech and Pharmaceutical Companies' Issuance of Stock Options, and Regulations Governing Application of Deferred Taxation of Income Tax in Accordance with the Act for the Development of Biotech and Pharmaceutical Industry

August 2022

Analysis of the 2022 Amendment to the Anti-Monopoly Law of the Mainland China

July 2022

Feature Articles on the Act for the Development of Biotech and Pharmaceutical Industry of Taiwan (IV) –The MOEA of Taiwan Announced the Regulatory Highlights of the Drafts Concerning the Tax Credits for the Income from Investment in Biological or Pharmaceutical Companies by Profit-seeking Enterprises or Individuals

July 2022

Construction Extension of Time and the Change of Critical Path (Taiwan)

July 2022

Focus on the Choice of Governing Law in Cross-Border Transactions (Mainland China)

July 2022

Analysis of the Criteria for Decisions to Rescind Contracts Based on Force Majeure and Change in Circumstances During an Epidemic (Mainland China)

July 2022

Feature Articles on the Act for the Development of Biotech and Pharmaceutical Industry of Taiwan (III) – The Draft Regulations Governing the Applicability of Investment Tax Credits to Biotech and Pharmaceutical Companies’ Investments in Machinery, Equipment or Systems, Which Is the Sub-law Pre-announced by the MOEA of Taiwan

July 2022

Regulations for the Implementation of the Drug Administration Law (Draft Revision for Comments) in Mainland China Focused Interpretation
< 7 8 9 10 11 12 13 14 15 16 >